These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8856259)

  • 1. Lipoprotein derangement during steroid treatment in minimal-change nephrotic syndrome.
    Tsukamoto Y; Kokubo T; Horii A; Moriya R; Kobayashi Y
    Nephron; 1996; 73(4):606-12. PubMed ID: 8856259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences.
    Vaziri ND
    Kidney Int; 2016 Jul; 90(1):41-52. PubMed ID: 27165836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome.
    Joven J; Villabona C; Vilella E; Masana L; Albertí R; Vallés M
    N Engl J Med; 1990 Aug; 323(9):579-84. PubMed ID: 2381443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acyl-coenzyme A:cholesterol acyltransferase inhibition ameliorates proteinuria, hyperlipidemia, lecithin-cholesterol acyltransferase, SRB-1, and low-denisty lipoprotein receptor deficiencies in nephrotic syndrome.
    Vaziri ND; Liang KH
    Circulation; 2004 Jul; 110(4):419-25. PubMed ID: 15262831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of lipid metabolism under different urinary protein excretion in children with primary nephrotic syndrome.
    Hu P; Lu L; Hu B; Du PF
    Scand J Clin Lab Invest; 2009; 69(6):680-6. PubMed ID: 19468931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein profiles in a heterogeneous group of patients with nephrotic syndrome.
    Michaeli J; Bar-On H; Shafrir E
    Isr J Med Sci; 1981 Nov; 17(11):1001-8. PubMed ID: 7319786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of serum lipid abnormalities in chronic nephritis.
    Hirano H; Yamada Y; Otani H; Kodama N; Mune M; Yukawa S
    Kidney Int Suppl; 1999 Jul; 71():S147-9. PubMed ID: 10412761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormalities in plasma lipoprotein in familial partial lecithin:cholesterol acyltransferase deficiency.
    Kodama T; Akanuma Y; Okazaki M; Aburatani H; Itakura H; Takahashi K; Sakuma M; Takaku F; Hara I
    Biochim Biophys Acta; 1983 Aug; 752(3):407-15. PubMed ID: 6871236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lipoproteins, apolipoproteins, lipoprotein lipase, hepatic triglyceride lipase and lecithin cholesterol acyltransferase in patients with nephrotic syndrome].
    Breier C; Lisch HJ; Drexel H; Braunsteiner H
    Schweiz Med Wochenschr; 1983 Jun; 113(25):909-13. PubMed ID: 6612272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid and lipoprotein abnormalities in renal disease.
    Segura R; Gotto AM
    Perspect Nephrol Hypertens; 1976; 3():159-200. PubMed ID: 814531
    [No Abstract]   [Full Text] [Related]  

  • 11. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia.
    Saku K; Sasaki J; Arakawa K
    Clin Ther; 1989; 11(2):247-57. PubMed ID: 2736571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in plasma lipids, lipoproteins and apolipoproteins in hypercholesterolaemic patients treated with pravastatin.
    Lijnen P; Celis H; Desager JP; Fagard R
    J Hum Hypertens; 1995 Jul; 9(7):557-64. PubMed ID: 7562885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implication of cholesterol in cyclosporine pharmacodynamics in minimal change nephrotic syndrome.
    Hirano T; Kawamura T; Fukuda S; Kohsaka S; Yoshikawa N; Yoshida M; Oka K
    Clin Pharmacol Ther; 2003 Dec; 74(6):581-90. PubMed ID: 14663460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with nephrotic-range proteinuria have apolipoprotein C and E deficient VLDL1.
    Deighan CJ; Caslake MJ; McConnell M; Boulton-Jones JM; Packard CJ
    Kidney Int; 2000 Sep; 58(3):1238-46. PubMed ID: 10972686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dyslipoproteinemia in an inbred rat strain with spontaneous chronic progressive nephrotic syndrome.
    Tarugi P; Nicolini S; Albertazzi L; Calandra S; Salvati P; Ferti C; Patrono C
    J Lipid Res; 1991 Oct; 32(10):1675-87. PubMed ID: 1797947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid parameters predicting liver function in patients with cirrhosis and after liver transplantation.
    Tietge UJ; Boker KH; Bahr MJ; Weinberg S; Pichlmayr R; Schmidt HH; Manns MP
    Hepatogastroenterology; 1998; 45(24):2255-60. PubMed ID: 9951906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective, one-year study on the effects of two long acting injectable contraceptives (depot-medroxyprogesterone acetate and norethisterone oenanthate) on serum and lipoprotein lipids.
    Enk L; Landgren BM; Lindberg UB; Silfverstolpe G; Crona N
    Horm Metab Res; 1992 Feb; 24(2):85-9. PubMed ID: 1533383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of desogestrel and gestodene in low-dose oral contraceptive combinations on lipid and lipoprotein status. A randomized prospective study.
    Granata A; Sobbrio GA; D'Arrigo F; Barillari M; Curasì MP; Egitto M; Trimarchi F; Granese D; Pullè C
    Acta Eur Fertil; 1990; 21(3):143-6. PubMed ID: 2149913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The causal role of hypoalbuminemia in human nephrotic hyperlipidemia.
    Rahman M; Salamatullah Q; Ferdous Z; Hussain MA
    Bangladesh Med Res Counc Bull; 1976 Jun; 2(1):64-70. PubMed ID: 190998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.